Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | Unity Biotechnology, Inc. UNBX | Alyeska Investment Group, L.P. | 1,578,091 9.170% | -89,823 (-5.39%) | Filing History |
| 2024-11-14 4:35 pm Sale | 2024-09-30 | 13G | Unity Biotechnology, Inc. UNBX | Alyeska Investment Group, L.P. | 1,667,914 9.990% | -8,904 (-0.53%) | Filing History |
| 2024-02-14 1:52 pm Purchase | 2023-12-31 | 13G | Unity Biotechnology, Inc. UNBX | Alyeska Investment Group, L.P. | 1,676,818 9.990% | 257,818 (+18.17%) | Filing History |
| 2023-05-10 09:45 am Sale | 2023-05-09 | 13G | Unity Biotechnology, Inc. UNBX | FMR LLC | 600,004 4.016% | -763,116 (-55.98%) | Filing History |
| 2023-02-14 2:07 pm Purchase | 2022-12-31 | 13G | Unity Biotechnology, Inc. UNBX | Alyeska Investment Group, L.P. | 1,419,000 9.990% | 1,419,000 (New Position) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | Unity Biotechnology, Inc. UNBX | FMR LLC | 1,363,120 9.215% | 1,363,120 (New Position) | Filing History |
| 2022-10-11 09:03 am Purchase | 2022-10-07 | 13G | Unity Biotechnology, Inc. UBX | FMR LLC | 1,354,322 9.658% | 22,000 (+1.65%) | Filing History |
| 2022-09-12 11:13 am Purchase | 2022-09-09 | 13G | Unity Biotechnology, Inc. UBX | FMR LLC | 1,332,322 14.975% | 1,021,669 (+328.88%) | Filing History |
| 2022-02-14 4:12 pm Unchanged | 2021-12-31 | 13G | Unity Biotechnology, Inc. UBX | Venrock Associates VII L.P. | 268,004 4.600% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:55 pm Purchase | 2021-12-31 | 13G | Unity Biotechnology, Inc. UBX | ARCH Venture Fund VII L.P. | 1,013,886 17.500% | 3,856 (+0.38%) | Filing History |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | Unity Biotechnology, Inc. UBX | FMR LLC | 310,653 5.381% | -147,709 (-32.23%) | Filing History |
| 2021-07-01 11:12 am Purchase | 2021-06-30 | 13G | Unity Biotechnology, Inc. UNBX | BAILLIE GIFFORD & CO | 2,479,068 4.520% | 2,479,068 (New Position) | Filing History |
| 2021-06-09 2:01 pm Sale | 2021-05-31 | 13G | Unity Biotechnology, Inc. UBX | BlackRock Inc. BLK | 271,148 4.900% | -17,017 (-5.91%) | Filing History |
| 2021-02-08 10:35 am Sale | 2021-02-05 | 13G | Unity Biotechnology, Inc. UBX | FMR LLC | 458,362 8.662% | -26,737 (-5.51%) | Filing History |
| 2021-02-02 5:03 pm Purchase | 2020-12-31 | 13G | Unity Biotechnology, Inc. UBX | ARCH Venture Fund VII L.P. | 1,010,030 19.100% | 3,856 (+0.38%) | Filing History |
| 2021-02-02 2:56 pm Purchase | 2020-12-31 | 13G | Unity Biotechnology, Inc. UBX | BlackRock Inc. BLK | 288,165 5.400% | 288,165 (New Position) | Filing History |
| 2021-01-14 12:29 pm Unchanged | 2020-12-31 | 13G | Unity Biotechnology, Inc. UBX | BAILLIE GIFFORD & CO | 380,301 7.190% | 0 (Unchanged) | Filing History |
| 2021-01-08 4:49 pm Purchase | 2018-12-31 | 13G | Unity Biotechnology, Inc. UBX | WuXi PharmaTech Healthcare Fund I L.P. | 147,799 2.800% | 147,799 (New Position) | Filing History |